Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.

Objective: To determine the clinical usefulness of prostate-specific antigen (PSA) density in the transition zone (PSADTZ) for increasing the specificity in early detection of

Objective: Determine how serum prostate-specific antigen (t-PSA) levels and free PSA (f/t PSA) ratio change following transurethral resection of the prostate (TURP).. Materials

Background: Prostate cancer (PCa) patients with pretreatment prostate-speciic antigen (PSA) >20 ng/ml have a high risk of biochemical and clinical failure and even

Conclusions: Patients with PSA recurrence and a negative post-radiation biopsy have a high chance of persistent local disease, progression, and death from prostate

Various variables may influence the cancer detection rates and diagnostic yield of prostate biop- sies such as; patient age and race, serum PSA level, prostate volume, biopsy

In our study, PSA fluctuation was correla- ted with baseline PSA levels, and not correlated with age, PSAD, %Free-PSA, and prostate volu- me.. Thus, we suggest that PSA

Several clinicopathologic findings of the patients were studied: age, race, clinical sta- ge, preoperative serum PSA, weight of the pros- tate in surgical specimen, pathologic

CONCLUSION: Percutaneous cryoablation of the prostate is a safe minimally invasive treatment, but it has poor PSA-free survival outcomes in high-risk prostate cancer